|
| 36512738 | Nivolumab Plus Cabozantinib With or Without Ipilimumab for Advanced Hepatocellular Carcinoma: Results From Cohort 6 of the CheckMate 040 Trial. | J Clin Oncol | 2023 |
| 37331369 | Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study. | Lancet | 2023 |
| 36999533 | Phase 2 trial of bintrafusp alfa as second-line therapy for patients with locally advanced/metastatic biliary tract cancers. | Hepatology | 2023 |
| 35326718 | Tumor Treating Fields Concomitant with Sorafenib in Advanced Hepatocellular Cancer: Results of the HEPANOVA Phase II Study. | Cancers (Basel) | 2022 |
| 35475258 | Tocilizumab in patients hospitalised with COVID-19 pneumonia: Efficacy, safety, viral clearance, and antibody response from a randomised controlled trial (COVACTA). | EClinicalMedicine | 2022 |
| 35789446 | Developing and Validating Multi-Modal Models for Mortality Prediction in COVID-19 Patients: a Multi-center Retrospective Study. | J Digit Imaging | 2022 |
| 35920133 | Efficacy and safety of dilpacimab (ABT-165) versus bevacizumab plus FOLFIRI in metastatic colorectal cancer: a phase IIÂ study. | Future Oncol | 2022 |
| 35151941 | Watch-and-Wait policy versus robotic surgery for locally advanced rectal cancer: A cost-effectiveness study (RECCOSTE). | Surg Oncol | 2022 |
| 35094895 | Efficacy and safety of therapeutic vs. prophylactic bemiparin in noncritically ill patients with COVID-19 pneumonia. | Eur J Intern Med | 2022 |
| 33197226 | Phase III Trial of Avelumab Maintenance After First-Line Induction Chemotherapy Versus Continuation of Chemotherapy in Patients With Gastric Cancers: Results From JAVELIN Gastric 100. | J Clin Oncol | 2021 |
| 33676792 | Complete pathological response to neoadjuvant treatment is associated with better survival outcomes in patients with soft tissue sarcoma: Results of a retrospective multicenter study. | Eur J Surg Oncol | 2021 |
| 34547581 | Trifluridine/tipiracil in combination with oxaliplatin and either bevacizumab or nivolumab in metastatic colorectal cancer: a dose-expansion, phase I study. | ESMO Open | 2021 |
| 34287771 | Toxicity and antitumor activity of novel agents in elderly patients with cancer included in phase 1 studies. | Invest New Drugs | 2021 |
| 34051329 | CheckMate 040 cohort 5: A phase I/II study of nivolumab in patients with advanced hepatocellular carcinoma and Child-Pugh B cirrhosis. | J Hepatol | 2021 |
| 32162804 | The McCAVE Trial: Vanucizumab plus mFOLFOX-6 Versus Bevacizumab plus mFOLFOX-6 in Patients with Previously Untreated Metastatic Colorectal Carcinoma (mCRC). | Oncologist | 2020 |
| 31912800 | Randomized, double-blind, placebo-controlled phase II study of istiratumab (MM-141) plus nab-paclitaxel and gemcitabine versus nab-paclitaxel and gemcitabine in front-line metastatic pancreatic cancer (CARRIE). | Ann Oncol | 2020 |
| 32641104 | Meta-analysis examining overall survival in patients with pancreatic cancer treated with second-line 5-fluorouracil and oxaliplatin-based therapy after failing first-line gemcitabine-containing therapy: effect of performance status and comparison with other regimens. | BMC Cancer | 2020 |
| 32507672 | Corrigendum to 'Randomized, double-blind, placebo-controlled phase II study of istiratumab (MM-141) plus nab-paclitaxel and gemcitabine versus nab-paclitaxel and gemcitabine in front-line metastatic pancreatic cancer (CARRIE)': Annals of Oncology, Volume 31, Issue 1, 2020, Pages 79-87. | Ann Oncol | 2020 |
| 30531832 | A phase 2 randomised study of veliparib plus FOLFIRI±bevacizumab versus placebo plus FOLFIRI±bevacizumab in metastatic colorectal cancer. | Br J Cancer | 2019 |
| 29975196 | Dynamic Angiogenic Switch as Predictor of Response to Chemotherapy-Bevacizumab in Patients With Metastatic Colorectal Cancer. | Am J Clin Oncol | 2019 |
| 31350526 | Correction: A phase 2 randomised study of veliparib plus FOLFIRI±bevacizumab versus placebo plus FOLFIRI±bevacizumab in metastatic colorectal cancer. | Br J Cancer | 2019 |
| 30458340 | Quality of life in metastatic pancreatic cancer patients receiving liposomal irinotecan plus 5-fluorouracil and leucovorin. | Eur J Cancer | 2019 |
| 29423521 | Efficacy of Sym004 in Patients With Metastatic Colorectal Cancer With Acquired Resistance to Anti-EGFR Therapy and Molecularly Selected by Circulating Tumor DNA Analyses: A Phase 2 Randomized Clinical Trial. | JAMA Oncol | 2018 |
| 29991024 | Efficacy and Safety of Sunitinib in Patients with Well-Differentiated Pancreatic Neuroendocrine Tumours. | Neuroendocrinology | 2018 |
| 30123970 | Randomized, double-blind, phase two study of ruxolitinib plus regorafenib in patients with relapsed/refractory metastatic colorectal cancer. | Cancer Med | 2018 |
| 29756206 | Phase I/II trial of pimasertib plus gemcitabine in patients with metastatic pancreatic cancer. | Int J Cancer | 2018 |
| 29588308 | Exome Sequencing of Plasma DNA Portrays the Mutation Landscape of Colorectal Cancer and Discovers Mutated VEGFR2 Receptors as Modulators of Antiangiogenic Therapies. | Clin Cancer Res | 2018 |
| 27873130 | Phase I clinical and pharmacokinetic study of PM01183 (a tetrahydroisoquinoline, Lurbinectedin) in combination with gemcitabine in patients with advanced solid tumors. | Invest New Drugs | 2017 |
| 28188407 | Phase II study of the antibody-drug conjugate TAK-264 (MLN0264) in patients with metastatic or recurrent adenocarcinoma of the stomach or gastroesophageal junction expressing guanylyl cyclase C. | Invest New Drugs | 2017 |
| 28350787 | Quality-adjusted survival with combination nal-IRI+5-FU/LV vs 5-FU/LV alone in metastatic pancreatic cancer patients previously treated with gemcitabine-based therapy: a Q-TWiST analysis. | Br J Cancer | 2017 |
| 28445610 | Population Pharmacokinetics of Liposomal Irinotecan in Patients With Cancer. | Clin Pharmacol Ther | 2017 |
| 29657584 | Dynamic Biomarkers of Response to Antiangiogenic Therapies in Colorectal Cancer: A Review. | Curr Pharmacogenomics Person Med | 2017 |
| 29113659 | A comparative study of neoadjuvant treatment with gemcitabine plus nab-paclitaxel versus surgery first for pancreatic adenocarcinoma. | Surg Oncol | 2017 |
| 28527133 | A phase II study of antibody-drug conjugate, TAK-264 (MLN0264) in previously treated patients with advanced or metastatic pancreatic adenocarcinoma expressing guanylyl cyclase C. | Invest New Drugs | 2017 |
| 27852040 | Clinical validation of prospective liquid biopsy monitoring in patients with wild-type RAS metastatic colorectal cancer treated with FOLFIRI-cetuximab. | Oncotarget | 2017 |
| 24517959 | Phase II Trial of Target-guided Personalized Chemotherapy in First-line Metastatic Colorectal Cancer. | Am J Clin Oncol | 2016 |
| 23211222 | A prospective pilot study of target-guided personalized chemotherapy with intensity-modulated radiotherapy in patients with early rectal cancer. | Am J Clin Oncol | 2014 |
| 24642623 | Reply: 'Comments on Stromal disrupting effects of nab-paclitaxel in pancreatic cancer'. | Br J Cancer | 2014 |
| 24715243 | Complete pathological responses in locally advanced rectal cancer after preoperative IMRT and integrated-boost chemoradiation. | Strahlenther Onkol | 2014 |
| 22669334 | A preclinical and clinical study of mycophenolate mofetil in pancreatic cancer. | Invest New Drugs | 2013 |
| 23907428 | Stromal disrupting effects of nab-paclitaxel in pancreatic cancer. | Br J Cancer | 2013 |
| 22713591 | Resected duodenal gastrointestinal stromal tumour with an affected margin and exon 9 mutation: adjuvant therapy. | Anticancer Drugs | 2012 |
| 20156784 | Mixed paratesticular liposarcoma with osteosarcoma elements. | Clin Transl Oncol | 2010 |
| 17681095 | Erlotinib as a single agent in select subsets of patients with advanced non-small-cell lung cancer. | Clin Lung Cancer | 2007 |
| 15738809 | Intra-articular traumatic disorders of the knee in children and adolescents. | Clin Orthop Relat Res | 2005 |
| 11319297 | Renal tolerance to cisplatin in patients 70 years and older. | Am J Clin Oncol | 2001 |
| 10934697 | [Update on breast cancer and pregnancy]. | Med Clin (Barc) | 2000 |
| 10846657 | [Current status of the treatment of hepatic metastases of colorectal carcinoma]. | Med Clin (Barc) | 2000 |
| 9442336 | Radiographic visualization of patellar tendon grafts for the reconstruction of the anterior cruciate ligament. | Arthroscopy | 1997 |